Literature DB >> 2831987

Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.

S Tornaletti1, A M Pedrini.   

Abstract

It has been recently found that, contrary to prior belief, norfloxacin, a member of the 4-quinolone family of antibacterial drugs that specifically inhibit DNA gyrase, does not bind to the enzyme but instead to DNA. We have performed DNA unwinding experiments in order to decide whether binding of norfloxacin to DNA introduces changes in its supercoiled conformation. We have found that: (i) norfloxacin and nalidixic acid are capable of unwinding the double helix, thus confirming the binding of these antibiotics to DNA; (ii) DNA unwinding can be observed only in the presence of Mg2+ and decreases with increasing KCl concentration; (iii) the extent of unwinding varies in different DNA molecules, suggesting a sequence preference of norfloxacin binding to DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831987     DOI: 10.1016/0167-4781(88)90153-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents.

Authors:  J F Barrett; T D Gootz; P R McGuirk; C A Farrell; S A Sokolowski
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

2.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

3.  Studies on interaction of norfloxacin, Cu2+, and DNA by spectral methods.

Authors:  Gongwu Song; Qiujun Yan; Yu He
Journal:  J Fluoresc       Date:  2005-09       Impact factor: 2.217

4.  Avian myeloblastosis virus reverse transcriptase inhibition by nalidixic acid.

Authors:  H Aoyama
Journal:  Mol Cell Biochem       Date:  1991-12-11       Impact factor: 3.396

Review 5.  In vitro assays used to measure the activity of topoisomerases.

Authors:  J F Barrett; J A Sutcliffe; T D Gootz
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

6.  Conversion of DNA gyrase into a conventional type II topoisomerase.

Authors:  S C Kampranis; A Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes.

Authors:  J Bedard; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

8.  Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.

Authors:  J Bedard; S Chamberland; S Wong; T Schollaardt; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Effect of magnesium complexation by fluoroquinolones on their antibacterial properties.

Authors:  S Lecomte; M H Baron; M T Chenon; C Coupry; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Quinolone binding to DNA is mediated by magnesium ions.

Authors:  G Palù; S Valisena; G Ciarrocchi; B Gatto; M Palumbo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.